Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint

Clinical and Vaccine Immunology

Volumn 20, Issue 6, 2013, Pages 803-810

  Porter, Michael D ^a   Nicki, Jennifer ^a   Pool, Christopher D ^a   DeBot, Margot ^a   Illam, Ratish M ^a   Brando, Clara ^a   Bozick, Brooke ^a   De La Vega, Patricia ^a   Angra, Divya ^a   Spaccapelo, Roberta ^b   Crisanti, Andrea ^c   Murphy, Jittawadee R ^a   Bennett, Jason W ^a   Schwenk, Robert J ^a   Ockenhouse, Christian F ^a   Dutta, Sheetij ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; IMMUNOGLOBULIN G; MALARIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE;

ANIMALS; ANTIBODIES, PROTOZOAN; CULICIDAE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED C57BL; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 84878287877     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00066-13     Document Type: Article

References (24)

1. Jin Y, Kebaier C, Vanderberg J. 2007. Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice. Infect. Immun. 75:5532-5539. (Pubitemid 350033643)
2. Meis JF, Verhave JP. 1988. Exoerythrocytic development of malarial parasites. Adv. Parasitol. 27:1-61.
3. Dame JB, Williams JL, McCutchan TF, Weber JL, Wirtz RA, Hockmeyer WT, Maloy WL, Haynes JD, Schneider I, Roberts D, Sanders GS, Reddy P, Diggs CL, Miller LH. 1984. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225:593-599. (Pubitemid 14053761)
4. Tewari R, Spaccapelo R, Bistoni F, Holder AA, Crisanti A. 2002. Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity. J. Biol. Chem. 277:47613-47618. (Pubitemid 36159282)
5. Vekemans J, Leach A, Cohen J. 2009. Development of the RTS,S/AS malaria candidate vaccine. Vaccine 27(Suppl 6):G67-G71.
6. Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G. 2009. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Vaccine 27:328-335.
7. Collins WE, Sullivan JS, Williams A, Galland GG, Nace D, Williams T, Barnwell JW. 2009. The Santa Lucia strain of Plasmodium falciparum in Aotus monkeys. Am. J. Trop. Med. Hyg. 80:536-540.
8. Hayes DE, Ward RA. 1977. Sporozoite transmission of falciparum malaria (Burma-Thau. strain) from man to Aotus monkey. Am. J. Trop. Med. Hyg. 26:184-185. (Pubitemid 8051449)
9. Collins WE, Sullivan JS, Morris CL, Galland GG, Richardson BB, Roberts JM. 1997. The Malayan IV strain of Plasmodium falciparum in Aotus monkeys. Am. J. Trop. Med. Hyg. 56:49-56. (Pubitemid 27097960)
10. Persson C, Oliveira GA, Sultan AA, Bhanot P, Nussenzweig V, Nardin E. 2002. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. J. Immunol. 169:6681-6685. (Pubitemid 36899251)
11. + T cell immunity and protection in mice. Infect. Immun. 81:789-800.
12. Ozaki LS, Gwadz RW, Godson GN. 1984. Simple centrifugation method for rapid separation of sporozoites from mosquitoes. J. Parasitol. 70:831-833. (Pubitemid 15194313)
13. Hollingdale MR, Nardin EH, Tharavanij S, Schwartz AL, Nussenzweig RS. 1984. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells: an in vitro assay of protective antibodies. J. Immunol. 132:909-913. (Pubitemid 14189116)
14. Schwenk RJ, Richie TL. 2011. Protective immunity to pre-erythrocytic stage malaria. Trends Parasitol. 27:306-314.
15. Myung JM, Marshall P, Sinnis P. 2004. The Plasmodium circumsporozoite protein is involved in mosquito salivary gland invasion by sporozoites. Mol. Biochem. Parasitol. 133:53-59. (Pubitemid 37510308)
16. Aldrich C, Magini A, Emiliani C, Dottorini T, Bistoni F, Crisanti A, Spaccapelo R. 2012. Roles of the amino terminal region and repeat region of the Plasmodium berghei circumsporozoite protein in parasite infectivity. PLoS One 7:e32524. doi:10.1371/journal.pone.0032524.
17. Coppi A, Pinzon-Ortiz C, Hutter C, Sinnis P. 2005. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J. Exp. Med. 201:27-33. (Pubitemid 40130080)
18. Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG, Jr, RTS,S Vaccine Evaluation Group. 2009. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200:337-346.
19. Roggero MA, Meraldi V, Lopez JA, Eberl G, Romero JC, Matile H, Betschart B, Corradin G, Renggli J. 2000. The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response. Eur. J. Immunol. 30:2679-2685.
20. Bergmann-Leitner ES, Scheiblhofer S, Weiss R, Duncan EH, Leitner WW, Chen D, Angov E, Khan F, Williams JL, Winter DB, Thalhamer J, Lyon JA, Tsokos GC. 2005. C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. Int. Immunol. 17:245-255. (Pubitemid 40372647)
21. Heppner DG, Gordon DM, Gross M, Wellde B, Leitner W, Krzych U, Schneider I, Wirtz RA, Richards RL, Trofa A, Hall T, Sadoff JC, Boerger P, Alving CR, Sylvester DR, Porter TG, Ballou WR. 1996. Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J. Infect. Dis. 174:361-366. (Pubitemid 26251423)
22. Doud MB, Koksal AC, Mi LZ, Song G, Lu C, Springer TA. 2012. Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proc. Natl. Acad. Sci. U. S. A. 109:7817-7822.
23. + T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine. PLoS One 7:e48304. doi:10.1371/journal.pone.0048304.
24. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.